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We have developed a modified molecular beacon melting curve analysis for rapid 
screening of Ethambutol (EMB) drug resistance and multi-drug MDR) resistance 
tuberculosis. A total of 107 isolates including 84 culture samples and 23 sputum were 
provided by Xiamen CDC, Shenzhen Center for Chronic disease Control and Peking 
University of Medical College. Our system was able to detect a single copy of M 
tuberculosis, screen out wild type from mutant type and even screen different bases 
mismatch. All the wild types and mutant types were confirmed wild types and mutant 
types by sequencing. The system could only detect M. tuberculosis giving a 
specificity of 100%. In order to reduce MDR in M. tuberculosis, we recommend our 
molecular method detection to rapidly adjust the therapy in drug resistance patients.
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XDR: extensively drug resistance






MIC: Minimal Inhibition Concentration
HIV: Human-immunodeficiency Vims
DNA: Deoxyribonucleic Acid
PCR: Polymerase Chain Reaction
RFLP: Restriction Fragment Length Polymorphisms
HA: Heteroduplex Analysis
ARMS-PCR: Amplification Refractory Mutation System Polymerase Chain Reaction
MAS-PCR: multiplex allele-specific
REMA: Resazurin Microtitre Assay
SSCP: single-stranded conformational polymorphism
MODS: Microscopic-observation Drug-susceptibility
CONRAS: Colorimetric nitrate reductase-based antibiotic susceptibility
NTM: Non-tuberculosis Mycobacterial
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